Application note: Resilient plastics in the Cold Chain
Posted: 2 June 2021 | Entegris | No comments yet
Pictorial that explains how Aramus TM single-layer fluoropolymer bag can withstand gamma irradiation and cold-chain temperatures down to -196°C.
Modern pharmaceutical bioprocessing often requires the use of a “Cold Chain”— an end-to-end temperature-controlled supply chain and work environment to ensure that compounds stay inert. However, single-use plastics often become brittle in cold temperatures, leading to bag failures and costly product loss. Entegris single-layer fluoropolymer bags built for biopharmaceutical applications are different. Here’s how.
Related content from this organisation
- ebook: A practical guide to single-use filtration in biopharma
- Biologics driving continuous bioprocessing market expansion
- On-demand webinar: Risk mitigation for single-use cold chain distribution
- Technical paper: Low risk frozen distribution of SU bags for bioprocessing
- Application note: Resilient plastics in the Cold Chain
Related topics
Biologics, Biopharmaceuticals, Bioprocessing, Biosimilars, Drug Delivery Systems, Freeze Drying, Gene therapy, Manufacturing, QA/QC, Research & Development (R&D), Stem Cells, Supply Chain, Vaccines